drugset
drugset / Trial / NCT02994290

Evaluation of the Implementation and Effectiveness of IPP-HPV

NCT02994290 ↗

Completed 817 enrolled Yale University National Cancer Institute (NCI) · collab
Non-randomizedSingle-groupOpen-labelHealth-services research

Summary

The purpose of the proposed pilot study is to assess the implementation of IPP-HPV immunization at Yale New Haven Hospital (YNHH) and to identify potential barriers to and facilitators of this intervention to optimize its feasibility and effectiveness. It is imperative that innovative interventions be developed to achieve comprehensive utilization of this highly effective vaccine to reduce rates of HPV infection, lower rates of cervical and other HPV associated cancers, and address cancer disparities.

Timeline

Start
2017-01
Primary completion
2021-10-31
Completion
2021-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil Vaccine — —

Indications

No indication recorded.